AngioDynamics Gross Profit 2010-2024 | ANGO

AngioDynamics gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
AngioDynamics Annual Gross Profit
(Millions of US $)
2024 $155
2023 $174
2022 $166
2021 $157
2020 $150
2019 $156
2018 $144
2017 $144
2016 $174
2015 $176
2014 $180
2013 $169
2012 $125
2011 $126
2010 $127
2009 $120
AngioDynamics Quarterly Gross Profit
(Millions of US $)
2024-11-30 $40
2024-08-31 $37
2024-05-31 $39
2024-02-29 $36
2023-11-30 $40
2023-08-31 $40
2023-05-31 $46
2023-02-28 $41
2022-11-30 $45
2022-08-31 $42
2022-05-31 $46
2022-02-28 $39
2021-11-30 $41
2021-08-31 $40
2021-05-31 $42
2021-02-28 $39
2020-11-30 $40
2020-08-31 $36
2020-05-31 $30
2020-02-29 $40
2019-11-30 $42
2019-08-31 $38
2019-05-31 $41
2019-02-28 $38
2018-11-30 $41
2018-08-31 $36
2018-05-31 $14
2018-02-28 $45
2017-11-30 $43
2017-08-31 $41
2017-05-31 $10
2017-02-28 $44
2016-11-30 $45
2016-08-31 $45
2016-05-31 $42
2016-02-29 $44
2015-11-30 $46
2015-08-31 $43
2015-05-31 $44
2015-02-28 $38
2014-11-30 $48
2014-08-31 $46
2014-05-31 $48
2014-02-28 $45
2013-11-30 $45
2013-08-31 $43
2013-05-31 $44
2013-02-28 $41
2012-11-30 $44
2012-08-31 $39
2012-05-31 $31
2012-02-29 $29
2011-11-30 $33
2011-08-31 $32
2011-05-31 $32
2011-02-28 $32
2010-11-30 $32
2010-08-31 $30
2010-05-31 $35
2010-02-28 $30
2009-11-30 $32
2009-08-31 $30
2009-05-31 $33
2009-02-28 $30
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.449B $0.304B
AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.062B 26.20
Intuitive Surgical (ISRG) United States $209.612B 96.16
Alcon (ALC) Switzerland $45.206B 30.25
Edwards Lifesciences (EW) United States $41.870B 26.59
IQVIA Holdings (IQV) United States $38.108B 20.48
IDEXX Laboratories (IDXX) United States $37.713B 43.16
DexCom (DXCM) United States $34.497B 51.95
Mettler-Toledo (MTD) United States $28.642B 32.97
Waters (WAT) United States $24.401B 36.08
STERIS (STE) Ireland $22.253B 25.33
SONOVA HOLDING (SONVY) Switzerland $20.160B 0.00
Hologic (HOLX) United States $14.774B 15.85
Fresenius Medical Care AG KGaA (FMS) Germany $14.260B 14.64
Globus Medical (GMED) United States $11.976B 30.33
Sysmex ADR (SSMXY) Japan $11.771B 36.91
Penumbra (PEN) United States $10.036B 98.31
Masimo (MASI) United States $9.638B 46.64
Glaukos (GKOS) United States $8.562B 0.00
Teleflex (TFX) United States $8.064B 12.86
Integer Holdings (ITGR) United States $4.726B 26.79
Inari Medical (NARI) United States $4.676B 0.00
PROCEPT BioRobotics (PRCT) United States $3.694B 0.00
Veracyte (VCYT) United States $3.371B 101.16
Nihon Kohden (NHNKY) Japan $2.700B 14.76
LivaNova (LIVN) United Kingdom $2.605B 15.04
TransMedics (TMDX) United States $2.467B 78.19
Tandem Diabetes Care (TNDM) United States $2.413B 0.00
Elekta AB (EKTAY) Sweden $2.332B 20.97
Integra LifeSciences Holdings (IART) United States $2.008B 10.49
Alphatec Holdings (ATEC) United States $1.620B 0.00
RxSight (RXST) United States $1.353B 0.00
Pulse Biosciences (PLSE) United States $1.340B 0.00
Artivion (AORT) United States $1.311B 86.86
OPKO Health (OPK) United States $1.106B 0.00
Paragon 28 (FNA) United States $1.088B 0.00
AxoGen (AXGN) United States $0.807B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.781B 13.27
IRadimed (IRMD) United States $0.778B 42.03
Mesa Laboratories (MLAB) United States $0.770B 16.83
SiBone (SIBN) United States $0.725B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.706B 0.00
Treace Medical Concepts (TMCI) United States $0.640B 0.00
OrthoPediatrics (KIDS) United States $0.574B 0.00
Delcath Systems (DCTH) United States $0.526B 0.00
ClearPoint Neuro (CLPT) United States $0.521B 0.00
Semler Scientific (SMLR) United States $0.463B 24.35
Pacific Biosciences Of California (PACB) United States $0.438B 0.00
Tactile Systems Technology (TCMD) United States $0.412B 22.30
NeuroPace (NPCE) United States $0.408B 0.00
CVRx (CVRX) United States $0.357B 0.00
Accuray (ARAY) United States $0.277B 0.00
Inogen (INGN) United States $0.258B 0.00
Alpha Tau Medical (DRTS) Israel $0.226B 0.00
Anteris Technologies Global (AVR) Australia $0.222B 0.00
KORU Medical Systems (KRMD) United States $0.222B 0.00
Nevro (NVRO) United States $0.214B 0.00
Sight Sciences (SGHT) United States $0.138B 0.00
Rapid Micro Biosystems (RPID) United States $0.133B 0.00
LENSAR (LNSR) United States $0.126B 0.00
Hyperfine (HYPR) United States $0.125B 0.00
Spectral Diagnostics (EDTXF) Canada $0.118B 0.00
Neuronetics (STIM) United States $0.108B 0.00
Atossa Genetics (ATOS) United States $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.100B 15.20
Monogram Orthopaedics (MGRM) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
908 Devices (MASS) United States $0.089B 0.00
Vicarious Surgical (RBOT) United States $0.081B 0.00
InspireMD (NSPR) Israel $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.061B 31.57
Lucid Diagnostics (LUCD) United States $0.057B 0.00
EnVVeno Medical (NVNO) United States $0.055B 0.00
Positron (POSC) United States $0.053B 0.00
Microbot Medical (MBOT) United States $0.044B 0.00
Baird Medical Investment Holdings (BDMD) $0.039B 0.00
Spectral AI (MDAI) United States $0.037B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Accelerate Diagnostics (AXDX) United States $0.032B 0.00
WORK Medical Technology Group (WOK) China $0.032B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
NexGel (NXGL) United States $0.023B 0.00
DarioHealth (DRIO) United States $0.021B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
Biosig Technologies (BSGM) United States $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Aspira Women's Health (AWH) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Tenon Medical (TNON) United States $0.005B 0.00
T2 Biosystems (TTOO) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00